Skip to main content
Top
Published in: Medical Oncology 10/2017

01-10-2017 | Short Communication

Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome

Authors: Anacélia Gomes de Matos, Howard Lopes Ribeiro Junior, Daniela de Paula Borges, Bruno Memória Okubo, Juliana Cordeiro de Sousa, Maritza Cavalcante Barbosa, Marilena Facundo de Castro, Romélia Pinheiro Gonçalves, Ronald Feitosa Pinheiro, Silvia Maria Meira Magalhães

Published in: Medical Oncology | Issue 10/2017

Login to get access

Abstract

The pathogenesis of myelodysplastic syndromes (MDS) is complex and depends on the interaction between aberrant hematopoietic cells and their microenvironment, probably including aberrations in cytokines and their signaling pathways. To evaluate interleukin-8 (IL-8) plasma levels and nuclear factor kappa B (NF-kB) in patients with MDS and to test possible correlation between IL-8 and NF-Kb, a total of 45 individuals were analyzed: 25 consecutive adult de novo MDS patients and 20 sex and age-matched healthy elderly volunteers. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. MDS patients showed higher level of IL-8 when compared to controls (p = 0.006). Patients aged 75 and above showed even higher levels (p = 0.035). NF-kB activity was significantly elevated in MDS patients when compared to controls (p < 0.0001) and higher in patients older than 75 years (p = 0.047). NF-kB activity was associated with higher serum ferritin (p = 0.042) and higher percentage of blasts (p = 0.028). A significant positive correlation between IL-8 and NF-kB was demonstrated (r = 0.480; p = 0.015). Many pathways involved in pathophysiology of MDS have been recently described, suggesting that an inflammatory process may act as a pathogenic driver. In this study, significantly elevated levels of IL-8 and NF-kB were demonstrated in MDS patients, with positive association of NF-kB with some markers of poor prognosis. A positive correlation between IL-8 and NF-kB suggests they cooperate as part of a complex networking of immune and inflammatory factors involved in MDS.
Literature
1.
go back to reference Gangat N, Patnaik MM, Tefferi A. Myelodysplastic syndromes: contemporary review. Am J Hematol. 2016;91:76–89.CrossRefPubMed Gangat N, Patnaik MM, Tefferi A. Myelodysplastic syndromes: contemporary review. Am J Hematol. 2016;91:76–89.CrossRefPubMed
2.
go back to reference Magalhaes SMM, Madeira TS, Bittencourt R, Velloso E, de Lourdes Chauffaille M, Azevedo AA, et al. Epidemiological and clinicopathological data from the Brazilian registry of patients with myelodysplastic syndromes and comparative analysis between different geographic areas. Blood. 2010;116(21):1884. Magalhaes SMM, Madeira TS, Bittencourt R, Velloso E, de Lourdes Chauffaille M, Azevedo AA, et al. Epidemiological and clinicopathological data from the Brazilian registry of patients with myelodysplastic syndromes and comparative analysis between different geographic areas. Blood. 2010;116(21):1884.
3.
go back to reference Magalhães SMM, Heredia FF, Fernandes LC, Sousa J, Almeida PJ, Souza GF, et al. Beyond race-related disparities: is myelodysplastic syndrome the same everywhere? Leuk Lymphoma. 2013;54:1564–6.CrossRefPubMed Magalhães SMM, Heredia FF, Fernandes LC, Sousa J, Almeida PJ, Souza GF, et al. Beyond race-related disparities: is myelodysplastic syndrome the same everywhere? Leuk Lymphoma. 2013;54:1564–6.CrossRefPubMed
4.
go back to reference Belli CB, Pinheiro RF, Bestach Y, et al. Myelodysplastic syndromes in South America: a multinational study of 1080 patients. Am J Hematol. 2015;90:851–8.CrossRefPubMed Belli CB, Pinheiro RF, Bestach Y, et al. Myelodysplastic syndromes in South America: a multinational study of 1080 patients. Am J Hematol. 2015;90:851–8.CrossRefPubMed
5.
go back to reference Gañán-Gómez I, Wei Y, Starczynowski DT, et al. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes. Leukemia. 2015;29:1458–69.CrossRefPubMedPubMedCentral Gañán-Gómez I, Wei Y, Starczynowski DT, et al. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes. Leukemia. 2015;29:1458–69.CrossRefPubMedPubMedCentral
7.
go back to reference GlenthØj A, Ørskov AD, Hansen JW, Sine RH, O’Connell C, Grønbæk K. Immune mechanisms in myelodysplastic syndrome. Int J Mol Sci. 2016;17:944.CrossRefPubMedCentral GlenthØj A, Ørskov AD, Hansen JW, Sine RH, O’Connell C, Grønbæk K. Immune mechanisms in myelodysplastic syndrome. Int J Mol Sci. 2016;17:944.CrossRefPubMedCentral
8.
go back to reference Wolach O, Stone R. Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol. 2016;136:108–17.CrossRefPubMed Wolach O, Stone R. Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol. 2016;136:108–17.CrossRefPubMed
10.
11.
12.
go back to reference Kornblau SM, McCue D, Singh N, et al. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010;116:4251–61.CrossRefPubMedPubMedCentral Kornblau SM, McCue D, Singh N, et al. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010;116:4251–61.CrossRefPubMedPubMedCentral
13.
go back to reference Singh J, Simões BM, Howell SJ, et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15:210.CrossRefPubMedPubMedCentral Singh J, Simões BM, Howell SJ, et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15:210.CrossRefPubMedPubMedCentral
14.
go back to reference Zhang M, Fanf T, Wang K, et al. Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies. Onco Targets Therapy. 2016;9:3727–37.CrossRef Zhang M, Fanf T, Wang K, et al. Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies. Onco Targets Therapy. 2016;9:3727–37.CrossRef
16.
go back to reference Braun T, Carvalho G, Coquelle A, et al. NFkB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156–65.CrossRefPubMed Braun T, Carvalho G, Coquelle A, et al. NFkB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156–65.CrossRefPubMed
17.
go back to reference Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kB as the matchmaker. Nat Immunol. 2011;12(8):715–23.CrossRefPubMed Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kB as the matchmaker. Nat Immunol. 2011;12(8):715–23.CrossRefPubMed
18.
19.
go back to reference Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65.CrossRefPubMedPubMedCentral Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65.CrossRefPubMedPubMedCentral
20.
go back to reference Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.CrossRefPubMed Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.CrossRefPubMed
21.
go back to reference Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed
22.
go back to reference Flülöp T, Dupuis G, Witkowski JM, et al. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin. 2016;68:84–91. Flülöp T, Dupuis G, Witkowski JM, et al. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin. 2016;68:84–91.
23.
go back to reference Meyers CA, Albitar M, Estey E. Cognitive impairment fatigue and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104:788–93.CrossRefPubMed Meyers CA, Albitar M, Estey E. Cognitive impairment fatigue and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104:788–93.CrossRefPubMed
24.
go back to reference He Q, Liu F. Unexpected role of inflammatory signaling in hematopoietic stem cell development: its role beyond inflammation. Curr Opin Hematol. 2016;23:18–22.CrossRefPubMed He Q, Liu F. Unexpected role of inflammatory signaling in hematopoietic stem cell development: its role beyond inflammation. Curr Opin Hematol. 2016;23:18–22.CrossRefPubMed
25.
go back to reference Porter JB, Garbowski M. The pathophysiology of transfusional iron overload. Hematol Oncol Clin N Am. 2014;28:683–701.CrossRef Porter JB, Garbowski M. The pathophysiology of transfusional iron overload. Hematol Oncol Clin N Am. 2014;28:683–701.CrossRef
26.
go back to reference Banerjee A, Mifsud NA, Bird R, et al. The oral iron chelator deferasirox inhibits NF-kB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anemia. Br J Haematol. 2015;168:576–82.CrossRefPubMed Banerjee A, Mifsud NA, Bird R, et al. The oral iron chelator deferasirox inhibits NF-kB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anemia. Br J Haematol. 2015;168:576–82.CrossRefPubMed
27.
go back to reference Yang L, Qian Y, Eksioglu E, et al. The inflammatory microenvironment in MDS. Cell Mol Life Sci. 2015;72:1959–66.CrossRefPubMed Yang L, Qian Y, Eksioglu E, et al. The inflammatory microenvironment in MDS. Cell Mol Life Sci. 2015;72:1959–66.CrossRefPubMed
Metadata
Title
Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome
Authors
Anacélia Gomes de Matos
Howard Lopes Ribeiro Junior
Daniela de Paula Borges
Bruno Memória Okubo
Juliana Cordeiro de Sousa
Maritza Cavalcante Barbosa
Marilena Facundo de Castro
Romélia Pinheiro Gonçalves
Ronald Feitosa Pinheiro
Silvia Maria Meira Magalhães
Publication date
01-10-2017
Publisher
Springer US
Published in
Medical Oncology / Issue 10/2017
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-017-1023-1

Other articles of this Issue 10/2017

Medical Oncology 10/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.